BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 14571744)

  • 1. Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.
    Liu HH; Huang TW; Chen HL; Wang TH; Lin JT
    Hepatogastroenterology; 2003; 50(53):1390-2. PubMed ID: 14571744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
    Lieberman DA; Weiss DG;
    N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-deficiency anemia due to chronic gastrointestinal bleeding.
    Reyes López A; Gómez Camacho F; Gálvez Calderón C; Miño Fugarolas G
    Rev Esp Enferm Dig; 1999 May; 91(5):345-58. PubMed ID: 10362876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic findings in the upper gastrointestinal tract of faecal occult blood-positive, colonoscopy-negative patients.
    Hisamuddin K; Mowat NA; Phull PS
    Dig Liver Dis; 2006 Jul; 38(7):503-7. PubMed ID: 16522381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high frequency of upper gastrointestinal pathology in patients with fecal occult blood and colon polyps.
    Geller AJ; Kolts BE; Achem SR; Wears R
    Am J Gastroenterol; 1993 Aug; 88(8):1184-7. PubMed ID: 8338085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic detection of fecal occult blood from upper digestive tract diseases.
    Nakama H; Kamijo N; Fattah AS; Zhang B
    Hepatogastroenterology; 1998; 45(21):752-4. PubMed ID: 9684127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive predictive value of fecal occult blood testing in persons taking warfarin.
    Bini EJ; Rajapaksa RC; Weinshel EH
    Am J Gastroenterol; 2005 Jul; 100(7):1586-92. PubMed ID: 15984986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of fecal occult blood test as a screening method for asymptomatic patients with colon polyps].
    Lee SH; Lee KS; Lee JY; Ji JH; Park JK; Park YS; Hwang JH; Kim JW; Jung SH; Kim N; Lee DH; Kim SG; Kim JS; Jung HC; Song IS
    Korean J Gastroenterol; 2006 Dec; 48(6):388-94. PubMed ID: 17189921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.
    Reilly JM; Ballantyne GH; Fleming FX; Zucker KA; Modlin IM
    Am Surg; 1990 Mar; 56(3):119-23. PubMed ID: 2316930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
    Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of isolated proximal colonic polyps among patients referred for colonoscopy.
    Lieberman DA; Smith FW
    Arch Intern Med; 1988 Feb; 148(2):473-5. PubMed ID: 3341844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional endoscopy in patients with fecal occult blood.
    Velez JP; Schwesinger WH; Stauffer J; Gaskill HV; Kazantsev GB; Sirinek KR; Strodel WE
    Surg Endosc; 2002 Jan; 16(1):117-20. PubMed ID: 11961620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
    Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flexible sigmoidoscopy in asymptomatic patients with negative fecal occult blood tests.
    Cauffman JG; Hara JH; Rasgon IM; Clark VA
    J Fam Pract; 1992 Mar; 34(3):281-6. PubMed ID: 1541954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.